Global /China /Healthcare /Drug Manufacturers - General /603079

Zhejiang Shengda Bio-Pharm Co., Ltd.

603079

• SSE: 603079 • Delayed

15.96CNY -0.8%

2.36 USD

As of 24 June 2026, Zhejiang Shengda Bio-Pharm Co., Ltd. has a market cap of $443.9M USD, ranking #15934 globally and #5015 in China. It ranks #1425 in the Healthcare sector, and #519 in the Drug Manufacturers - General industry.

Global Rank

15934

Country Rank

5015

Sector Rank

1425

Industry Rank

519

Key Stats

Market Cap

$443.9MUSD

3.01B CNY

Enterprise Value

$409.97MUSD

2.78B CNY

Revenue (TTM)

$122.43MUSD

830.53M CNY

EBITDA (TTM)

$22.33MUSD

151.17M CNY

Net Income (TTM)

$7.9MUSD

53.62M CNY

EBITDA Margin

18%

Profit Margin

6.5%

PE Ratio

54.9

PS Ratio

3.6

PB Ratio

1.8

EV/EBITDA

18.2

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Bin Zhou open_in_new

Employees

1,035

Founded

1999

Website

sd-pharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.8%	-3.8%	-6.2%	-21%	-13%	-9.9%	-6.1%	28%	-14%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	603079 浙江圣达生物药业股份有限公司 Class A ISIN: CNE100002W43 Shares Out.: Shares Outstanding: 187.438M¹ Shares Float: 143.79M² TV: TradingView: SSE: 603079 SA: Stock Analysis: SHA: 603079 YF: Yahoo Finance: 603079.SS GF: Google Finance: SHA: 603079 BA: Barron's: 603079 MS: Morningstar: XSHG: 603079	15.96 CNY	TV: TradingView: SSE: 603079 SA: Stock Analysis: SHA: 603079 YF: Yahoo Finance: 603079.SS GF: Google Finance: SHA: 603079 BA: Barron's: 603079 MS: Morningstar: XSHG: 603079

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Zhejiang Shengda Bio-Pharm Co., Ltd.

Zhejiang Shengda Bio-Pharm Co., Ltd. develops, produces, and sells food and feed additives for pharmaceutical, nutritional, food, and animal feed industry. It offers vitamins, such as biotin and folic acid; biological preservatives, including nisin, polylysine, and natamycin; and intermediate APIs. The company was incorporated in 1999 and is headquartered in Tiantai, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.79B 364.89B CNY 12K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.58B 336.36B CNY 11K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.5B 223.48B HKD 6K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.79B 147.32B HKD 4K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.49B 111.89B CNY 4K%	-	China
Akeso, Inc. SHEK: 9926	$16.0B 125.46B HKD 4K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 171K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 123K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 81K%	97.4	United States
Roche Holding AG SIX: RO	$316.71B 256.25B CHF 71K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$285.49B 215.59B GBP 64K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 62K%	15.1	United States

chevron_leftBack